Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia

Published:2023-04-27 Issue:17 Volume:388 Page:1572-1581
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

van der Sluis Inge M.¹^ORCID,de Lorenzo Paola¹,Kotecha Rishi S.¹^ORCID,Attarbaschi Andishe¹^ORCID,Escherich Gabriele¹,Nysom Karsten¹,Stary Jan¹,Ferster Alina¹,Brethon Benoit¹,Locatelli Franco¹^ORCID,Schrappe Martin¹,Scholte-van Houtem Peggy E.¹,Valsecchi Maria G.¹,Pieters Rob¹

Affiliation:

1. From the Princess Máxima Center for Pediatric Oncology (I.M.S., P.E.S.-H., R.P.), and the Dutch Childhood Oncology Group (I.M.S., R.P.) — both in Utrecht, the Netherlands; Tettamanti Center (P.L.) and Biostatistics and Clinical Epidemiology (M.G.V.), Fondazione IRCCS San Gerardo dei Tintori, Monza, the School of Medicine and Surgery, University of Milano-Bicocca, Milan (M.G.V.), and the Department of Pediatric Hematology–Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic...

Funder

Princess Máxima Center Foundation

Amgen

Australian Government’s Medical Research Future Fund

Erasmus MC Sophia Foundation

Federation Enfants et Santé and the Société Française de lute contre les cancers et les leucémies de l’enfant et de l’adolescent

Børnecancerfonden

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link